Pubblicazioni

Understanding and overcoming resistance to tyrosine kinase inhibitors (TKIs) in Chronic myeloid leukemia (CML)

2024 - EXPERT REVIEW OF HEMATOLOGY
Laganà, Alessandro; Scalzulli, Emilia; Bisegna, Maria Laura; Ielo, Claudia; Martelli, Maurizio; Breccia, Massimo

Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients

2022 - EXPERT REVIEW OF HEMATOLOGY
Breccia, M.; Scalzulli, E.; Pepe, S.; Colafigli, G.; Bisegna, M. L.; Capriata, M.; Martelli, M.

From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia care

2022 - EXPERT REVIEW OF HEMATOLOGY
Assanto, Giovanni Manfredi; Scalzulli, Emilia; Carmosino, Ida; Martelli, Maurizio; Breccia, Massimo

Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy

2022 - EXPERT REVIEW OF HEMATOLOGY
Perrone, Salvatore; Lopedote, Paolo; Levis, Mario; Di Rocco, Alice; Smith, Stephen Douglas

Measuring prognosis in chronic myeloid leukemia: what's new?

2021 - EXPERT REVIEW OF HEMATOLOGY
Breccia, Massimo; Efficace, Fabio; Scalzulli, Emilia; Ciotti, Giulia; Maestrini, Giacomo; Colafigli, Gioia; Martelli, Maurizio

Optimizing health-related quality of life in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors

2021 - EXPERT REVIEW OF HEMATOLOGY
Efficace, Fabio; Vignetti, Marco; Sparano, Francesco; Scalzulli, Emilia; Breccia, Massimo

Measuring prognosis in chronic myeloid leukemia: what's new?

2021 - EXPERT REVIEW OF HEMATOLOGY
Breccia, Massimo; Efficace, Fabio; Scalzulli, Emilia; Ciotti, Giulia; Maestrini, Giacomo; Colafigli, Gioia; Martelli, Maurizio

Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature review

2021 - EXPERT REVIEW OF HEMATOLOGY
Efficace, Fabio; Cannella, Laura; Breccia, Massimo; Olivieri, Jacopo; Platzbecker, Uwe; Vignetti, Marco

A review of current induction strategies and emerging prognostic factors in the management of children and adolescents with acute lymphoblastic leukemia

2020 - EXPERT REVIEW OF HEMATOLOGY
Capria, S.; Molica, M.; Mohamed, S.; Bianchi, S.; Moleti, Ml.; Trisolini, Sm.; Chiaretti, S.; Testi, Am.

The advantages and risks of ruxolitinib for the treatment of polycythemia vera

2020 - EXPERT REVIEW OF HEMATOLOGY
Colafigli, G.; Scalzulli, E.; Pepe, S.; Di Prima, A.; Efficace, F.; Martelli, M.; Foa, R.; Breccia, M.

Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia: a critical review of the current practice

2020 - EXPERT REVIEW OF HEMATOLOGY
Breccia, Massimo; Efficace, Fabio; Colafigli, Gioia; Scalzulli, Emilia; Di Prima, Alessio; Martelli, Maurizio; Foà, Robin

Advances in managing rare acquired bleeding disorders

2020 - EXPERT REVIEW OF HEMATOLOGY
Franchini, M.; Marano, G.; Cruciani, M.; Mengoli, C.; Pati, I.; Masiello, F.; Veropalumbo, E.; Pupella, S.; Vaglio, S.; Liumbruno, G. M.

The advantages and risks of ruxolitinib for the treatment of polycythemia vera

2020 - EXPERT REVIEW OF HEMATOLOGY
Colafigli, Gioia; Scalzulli, Emilia; Pepe, Sara; DI PRIMA, Alessio; Efficace, Fabio; Martelli, Maurizio; Foa, Robin; Breccia, Massimo

Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia

2019 - EXPERT REVIEW OF HEMATOLOGY
Breccia, M.; Foa, R.

Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia

2019 - EXPERT REVIEW OF HEMATOLOGY
Breccia, Massimo; Robin, Foà

Balancing efficacy and toxicity of targeted agents currently used for the treatment of patients with chronic lymphocytic leukemia

2018 - EXPERT REVIEW OF HEMATOLOGY
Mauro, Fr; Caputo, Md; Rosati, S; Pepe, S; De Benedittis, D; DE LUCA, MARIA LUCIA; Foà, R.

Current and future role of bispecific t-cell engagers in pediatric acute lymphoblastic leukemia

2018 - EXPERT REVIEW OF HEMATOLOGY
Algeri, M.; Del Bufalo, F.; Galaverna, F.; Locatelli, F.

Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia

2018 - EXPERT REVIEW OF HEMATOLOGY
Locatelli, F.; Algeri, M.; Merli, P.; Strocchio, L.

Novel tyrosine-kinase inhibitors for the treatment of chronic myeloid leukemia: safety and efficacy

2018 - EXPERT REVIEW OF HEMATOLOGY
Massaro, F; Colafigli, G; Molica, M; Breccia, M

Is now the time for molecular driven therapy for diffuse large B-cell lymphoma?

2017 - EXPERT REVIEW OF HEMATOLOGY
DI ROCCO, Alice; DE ANGELIS, Federico; Ansuinelli, Michela; Foa, Roberto; Martelli, Maurizio

From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?

2017 - EXPERT REVIEW OF HEMATOLOGY
Visentini, M; Fiorilli, M; Casato, M.

Direct oral anticoagulant reversal: how, when and issues faced

2017 - EXPERT REVIEW OF HEMATOLOGY
Dzeshka, Mikhail S.; Pastori, Daniele; Lip, Gregory Y. H.

How ruxolitinib modified the outcome in myelofibrosis: focus on overall survival, allele burden reduction and fibrosis changes

2017 - EXPERT REVIEW OF HEMATOLOGY
Massaro, F; Molica, M; Breccia, M

Splenic marginal zone lymphoma : Prognostic factors ,role of watch and wait policy ,and othert herapeutic approaches in the rituximab era

2016 - EXPERT REVIEW OF HEMATOLOGY
Capria, Saveria; Barberi, Walter; Perrone, Salvatore; Ferretti, Antonietta; Salaroli, Adriano; Annechini, Giorgia; D’Elia, Gianna Maria; Foà, Robin; Pulsoni, Alessandro

Management of elderly and unfit patients with chronic lymphocytic leukemia

2016 - EXPERT REVIEW OF HEMATOLOGY
Mauro, Francesca Romana; Salaroli, Adriano; Caputo, Maria Denise; Colafigli, Gioia; Petrucci, Luigi; Campanelli, Melissa; Ferretti, Antonietta; Guarini, Anna; Foa, Roberto

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma